Starling Oncology STLN
NASDAQ STLN
$5.97 -0.12 (-1.97%)
At close: Sep 3, 2026 · 4:00 PM EDT

Starling Oncology (STLN) Change in Receivables (2021 - 2026)

Analysis

Starling Oncology (STLN) Change in Receivables (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 HCA Healthcare 90.36 Bn 89.35 Bn 15.19 Bn 954.00 Mn
2 Tenet Healthcare 22.02 Bn 19.85 Bn 4.45 Bn 5.00 Mn
3 Encompass Health 12.13 Bn 11.99 Bn 1.34 Bn 10.20 Mn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn -5.55 Mn
5 Universal Health Services 10.09 Bn 9.95 Bn 3.29 Bn 14.05 Mn
6 Ensign 9.97 Bn 9.65 Bn 306.24 Mn 5.61 Mn
7 Chemed 6.93 Bn 6.89 Bn 221.47 Mn -26.18 Mn
8 Pacs 6.81 Bn 6.64 Bn 338.46 Mn -13.54 Mn
9 Concentra Group Holdings Parent 4.32 Bn 4.16 Bn 192.10 Mn 3.35 Mn
10 Starling Oncology 609.95 Mn 568.85 Mn 27.17 Mn 8.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.22 Mn
Mar 31, 2026 -864,000.00
Dec 31, 2025 -641,000.00
Sep 30, 2025 3.98 Mn
Jun 30, 2025 7.98 Mn
Mar 31, 2025 985,000.00
Dec 31, 2024 -6.17 Mn
Sep 30, 2024 485,000.00
Jun 30, 2024 -4.74 Mn
Mar 31, 2024 16.40 Mn
Dec 31, 2023 -4.09 Mn
Sep 30, 2023 2.08 Mn
Jun 30, 2023 435,000.00
Mar 31, 2023 6.14 Mn
Dec 31, 2022 5.07 Mn
Sep 30, 2022 6.02 Mn
Jun 30, 2022 4.54 Mn
Mar 31, 2022 4.66 Mn
Dec 31, 2021 -2.00 Mn
Sep 30, 2021 2.40 Mn